sphingosine kinase 2 inhibitors (University of Strathclyde)

N/A

Report date: 2025/03/20 10:11:49
NME

Base Information

Drug Namesphingosine kinase 2 inhibitors (University of Strathclyde)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase 2 inhibitors
TargetsSphingosine kinase 2
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Strathclyde
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A